05910252 is referenced by 176 patents and cites 46 patents.

Blood from a patient is treated extracorporeally by any selected one of a plurality of predetermined treatments. Each of the treatments involves the flow of blood from the patient into a primary chamber of a filtration unit, past a semipermeable membrane located in the filtration unit which separates the primary chamber from a secondary chamber of the filtration unit, out the filtration unit and back to the patient. A replacement fluid is selectively and controllably added to the blood, as required for the selected treatment. A secondary fluid is controllably and selectively introduced into the secondary chamber of the filtration unit for controllably collecting material passing across the semipermeable membrane from the blood or for supplying material to pass across the semipermeable membrane into the blood as required for the selected treatment. Materials are removed from the secondary chamber and collected in accordance with the selected treatment. Upon selection of one of the plurality of extracorporeal blood treatments available, the rates of blood flow, fluid flow and fluid collection during the extracorporeal treatment are automatically determined, established and monitored in accordance with the selected treatment. An apparatus which automatically performs and monitors the selected treatment is also described.

Title
Technique for extracorporeal treatment of blood
Application Number
8/17571
Publication Number
5910252
Application Date
February 12, 1993
Publication Date
June 8, 1999
Inventor
Lawrence L Leppert
Littleton
CO, US
Steven H Johnson
Lakewood
CO, US
George J Eilers
Evergreen
CO, US
Keith Manica
Lakewood
CO, US
Douglas P Miller
Broomfield
CO, US
Donn D Lobdell
Corona Del Mar
CA, US
Frank Corbin III
Littleton
CO, US
Lori A Truitt
Golden
CO, US
Agent
Carol W Holland & Hart Burton
Assignee
COBE Laboratories
CO, US
IPC
A61M 1/34
B01D 61/00
B01D 61/32
B01D 61/22
View Original Source